Literature DB >> 22083155

Congenital lipoid adrenal hyperplasia (a rare form of adrenal insufficiency and ambiguous genitalia) caused by a novel mutation of the steroidogenic acute regulatory protein gene.

Oksana Lekarev1, Delphine Mallet, Tony Yuen, Yves Morel, Maria I New.   

Abstract

UNLABELLED: Congenital lipoid adrenal hyperplasia (lipoid CAH) is a rare autosomal recessive disorder of adrenal and gonadal steroidogenesis. It is most frequently caused by mutations in the steroidogenic acute regulatory protein (StAR) gene. Patients with lipoid CAH typically present with adrenal crisis in early infancy, and those with a 46,XY karyotype have female genitalia. However, it has been recently recognized that the phenotype can be quite variable, in that adrenal insufficiency is detected later in life and patients may have partially masculinized or even normal male genitalia. We report a patient assigned and reared as a female with a 46,XY karyotype and with a homozygous intron 2 (c.178+1G>C) splice site mutation of the StAR gene, which is a novel mutation that causes lipoid CAH. Her clinical presentation was somewhat atypical for a patient with classic lipoid CAH, marked by mild masculinization of the genitalia, detectable adrenal steroids at baseline, and ability to tolerate the stress of a surgical procedure with anesthesia without receiving glucocorticoid treatment.
CONCLUSION: There is significant phenotypic variability among patients with lipoid CAH. While splice site mutations in the StAR gene lead to premature translational termination, resulting in truncated and non-functional proteins, there is phenotypic variability among patients with such mutations. Our patient appears to have the more atypical phenotype compared to reported patients with similar mutations. The molecular mechanism underlying this heterogeneity remains unclear.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083155     DOI: 10.1007/s00431-011-1620-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia.

Authors:  K M Caron; S C Soo; W C Wetsel; D M Stocco; B J Clark; K L Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Phenotypic features associated with mutations in steroidogenic acute regulatory protein.

Authors:  Amrit Bhangoo; Wen-Xia Gu; Steven Pavlakis; Henry Anhalt; Linda Heier; Svetlana Ten; J Larry Jameson
Journal:  J Clin Endocrinol Metab       Date:  2005-08-23       Impact factor: 5.958

3.  Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action.

Authors:  F Arakane; T Sugawara; H Nishino; Z Liu; J A Holt; D Pain; D M Stocco; W L Miller; J F Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR).

Authors:  Taninee Sahakitrungruang; Raymond E Soccio; Mariarosaria Lang-Muritano; Joanna M Walker; John C Achermann; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

5.  A novel compound heterozygous mutation in the steroidogenic acute regulatory protein gene in a patient with congenital lipoid adrenal hyperplasia.

Authors:  N Katsumata; Y Kawada; Y Yamamoto; M Noda; A Nimura; R Horikawa; T Tanaka
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

6.  Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency.

Authors:  T Tajima; K Fujieda; N Kouda; J Nakae; W L Miller
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Molecular and structural analysis of two novel StAR mutations in patients with lipoid congenital adrenal hyperplasia.

Authors:  J C Achermann; J J Meeks; B Jeffs; U Das; P E Clayton; C G Brook; J L Jameson
Journal:  Mol Genet Metab       Date:  2001-08       Impact factor: 4.797

Review 8.  Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter.

Authors:  Walter L Miller
Journal:  Biochim Biophys Acta       Date:  2007-03-06

9.  Congenital lipoid adrenal hyperplasia caused by a novel splicing mutation in the gene for the steroidogenic acute regulatory protein.

Authors:  Alexis A González; M Loreto Reyes; Cristian A Carvajal; Jaime A Tobar; Lorena M Mosso; Paulina Baquedano; Antonieta Solar; Alejandro Venegas; Carlos E Fardella
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

10.  The mechanism of action of steroidogenic acute regulatory protein (StAR). StAR acts on the outside of mitochondria to stimulate steroidogenesis.

Authors:  F Arakane; C B Kallen; H Watari; J A Foster; N B Sepuri; D Pain; S E Stayrook; M Lewis; G L Gerton; J F Strauss
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

View more
  3 in total

Review 1.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

2.  p.R182C mutation in Korean twin with congenital lipoid adrenal hyperplasia.

Authors:  Hye Won Park; Byung Ok Kwak; Gu-Hwan Kim; Han-Wook Yoo; Sochung Chung
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-03-31

Review 3.  Adrenal disorders in pregnancy.

Authors:  Silvia Monticone; Richard J Auchus; William E Rainey
Journal:  Nat Rev Endocrinol       Date:  2012-09-11       Impact factor: 43.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.